Carroll Financial Associates’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $21K | Hold |
191
| – | – | ﹤0.01% | 968 |
|
|
2021
Q3 | $24K | Buy |
191
+50
| +35% | +$6.28K | ﹤0.01% | 949 |
|
|
2021
Q2 | $19K | Sell |
141
-1,908
| -93% | -$257K | ﹤0.01% | 1113 |
|
|
2021
Q1 | $278K | Buy |
2,049
+41
| +2% | +$5.56K | 0.02% | 337 |
|
|
2020
Q4 | $282K | Buy |
2,008
+858
| +75% | +$120K | 0.02% | 310 |
|
|
2020
Q3 | $128K | Sell |
1,150
-2,527
| -69% | -$281K | 0.01% | 429 |
|
|
2020
Q2 | $411K | Buy |
3,677
+3,536
| +2,508% | +$395K | 0.03% | 246 |
|
|
2020
Q1 | $10K | Hold |
141
| – | – | ﹤0.01% | 953 |
|
|
2019
Q4 | $13K | Hold |
141
| – | – | ﹤0.01% | 989 |
|
|
2019
Q3 | $10K | Hold |
141
| – | – | ﹤0.01% | 1017 |
|
|
2019
Q2 | $12K | Hold |
141
| – | – | ﹤0.01% | 964 |
|
|
2019
Q1 | $12K | Sell |
141
-100
| -41% | -$8.51K | ﹤0.01% | 899 |
|
|
2018
Q4 | $19K | Hold |
241
| – | – | ﹤0.01% | 688 |
|
|
2018
Q3 | $23K | Hold |
241
| – | – | ﹤0.01% | 670 |
|
|
2018
Q2 | $22K | Hold |
241
| – | – | ﹤0.01% | 655 |
|
|
2018
Q1 | $21K | Buy |
241
+100
| +71% | +$8.71K | ﹤0.01% | 664 |
|
|
2017
Q4 | $11K | Hold |
141
| – | – | ﹤0.01% | 814 |
|
|
2017
Q3 | $12K | Hold |
141
| – | – | ﹤0.01% | 781 |
|
|
2017
Q2 | $10K | Buy |
+141
| New | +$10K | ﹤0.01% | 839 |
|